Low blood sugar levels in the newborn infant: Do changing goal posts matter?

David H Adamkin1

  • 1Division of Neonatal Medicine, Department of Pediatrics, University of Louisville School of Medicine, 571 South Floyd Street, Suite 342, Louisville, Kentucky, 40202-3830, USA.

Insights

Neonatal hypoglycemia and hyperglycemia impact fetal and newborn brain development. This review contrasts guidelines on defining neonatal hypoglycemia, exploring evidence-based practices, pathogenesis, and management strategies.

Area of Science:

  • Neonatal medicine
  • Pediatric endocrinology
  • Metabolic disorders

Background:

  • Glucose is vital for fetal and newborn growth and brain development.
  • Disruptions in glucose metabolism lead to hypoglycemia or hyperglycemia.
  • Current practices for defining neonatal hypoglycemia vary.

Purpose of the Study:

  • To contrast American Academy of Pediatrics and Pediatric Endocrine Society guidelines on neonatal hypoglycemia.
  • To review recent studies contributing to the controversy in defining neonatal hypoglycemia.
  • To discuss evidence-based guidelines, pathogenesis, outcomes, and management of neonatal glucose disorders.

Main Methods:

  • Literature review of recent studies and existing guidelines.
  • Comparative analysis of recommendations from major pediatric societies.
  • Synthesis of evidence on definitions, pathogenesis, and management.

Main Results:

  • Contrasting definitions of neonatal hypoglycemia exist between major pediatric organizations.
  • Recent research adds complexity to the ongoing debate on hypoglycemia thresholds.
  • Variations in clinical practices are evident.

Conclusions:

  • A unified definition and approach to neonatal hypoglycemia are needed.
  • Further research and trials are necessary to establish optimal management strategies.
  • Evidence-based guidelines are crucial for improving neonatal outcomes.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
530
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
120
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89